March 18, 2009 6:54 AM
- Text
Abbott CEO White Takes a Pay Cut
(MoneyWatch) Abbott Labs CEO Miles White took a pay cut last year. His total compensation was only $28.3 million, down from $33.3 million the year before, per a proxy filing at the SEC.
The cut came despite the judgment by Abbott's board that White "exceeded" his strategic and financial goals. Abbott's stock outperformed the S&P 500 last year. Revenue and profits were both up. The company said:
The cut came despite the judgment by Abbott's board that White "exceeded" his strategic and financial goals. Abbott's stock outperformed the S&P 500 last year. Revenue and profits were both up. The company said:
Therefore, in February 2009, the Committee awarded Mr. White a Performance Incentive Plan bonus of $4,200,000 for his performance in 2008, intended to recognize his leadership in guiding the Company's industry leading performance.Here's a summary of who earned what:
- Name, 2008 pay, 2007 pay
- CEO Miles D. White, $28.3 million, $33.3 million
- CFO Thomas C. Freyman, $6.8 million, $8.7 million
- EVP John M. Capek, $5.3 million, NA
- General counsel Laura J. Schumacher, $5.7 million, NA
- EVP James L. Tyree, $6.2 million, $5.7 million
- Source: SEC, numbers have been rounded.
Non-business related flights on corporate aircraft are covered by time-sharing lease agreements, pursuant to which certain costs associated with those flights are reimbursed in accordance with Federal Aviation Administration regulations. Messrs. White and Freyman have such agreements and reimbursed the Company.
- See previous BNET stories on pharma executive compensation:
- Gilead Executive Pay: Modest Raises for Outstanding Performance
- Gilead Deal Gives CV Therapeutics CEO $8.4 Million Payday Despite Lack of Profits
- Pfizer's Kindler Got $4.2 Million Pay Raise, Despite What Business Press Says
- Pfizer Execs' Golden Parachute Is Actually a Pay Cut
- Gilead Deal Gives CV Therapeutics CEO $8.4 Million Payday Despite Lack of Profits
- Genentech's Levinson May Have No Change-of-Control Agreement in Roche Deal
- Amgen CEO Sharer: Options? No Thanks. I'll Just Take the Cash.
- Schering CEO Hassan Has $59 Million Buyout Agreement in Merck Merger
- Merck Executive Pay: $36 million, Use of Private Jet, Cash Bonuses Despite Failures
- Eli Lilly Execs Receive $48 Million in Pay; Plus Chairman Taurel Adds $40 Million Nest Egg
- Novo Nordisk Executive Compensation: A Picture of Modesty (Except for the Car Expenses)
- How Pharma's CEO Pay Packages Measure Up
Latest Now in MoneyWatch
- Insurers respond cautiously to contraceptive plan
- Judge: Legally, breastfeeding not related to pregnancy
- Budget deficit drops to $27 billion in January
- Why the Powerball Jackpot is part of my investment strategy
- Is the new VW Beetle diesel worth the money?
- Consumer sentiment highlights risks to recovery
- Valentine blues? 10 best cities to be single
- December trade deficit widens to $48.8 billion
- Alcatel-Lucent returns to profit in 2011
- 6 things never to say in a performance review
- $26B mortgage deal: Who gets the money?
- Friendly's CEO steps down
- Quarterly loss hits $3.3B at Postal Service
- Greeks rail against cuts as EU demands more
- 6 things you should never share on Facebook
- Make moves now to increase financial aid
- Valentine's Day: 9 places to save
Latest CBS News Headlines
on Facebook
on CBS News
- No charges against NYPD boss' son after rape claim
- Hazing court martial begins for Marine sergeant
- 2 dead, 2 hurt after Texas transit stop shooting
- History expert pleads guilty to stealing documents
on Facebook
- Adele sings a cappella for Anderson Cooper
- Josh Powell had "incestuous" images on his home computer, authorities say
on CBS News






